CA2022681A1 - Derives de 2-(2-vinylpyrrolidinylthio)carbapenem - Google Patents

Derives de 2-(2-vinylpyrrolidinylthio)carbapenem

Info

Publication number
CA2022681A1
CA2022681A1 CA2022681A CA2022681A CA2022681A1 CA 2022681 A1 CA2022681 A1 CA 2022681A1 CA 2022681 A CA2022681 A CA 2022681A CA 2022681 A CA2022681 A CA 2022681A CA 2022681 A1 CA2022681 A1 CA 2022681A1
Authority
CA
Canada
Prior art keywords
group
hydrogen atom
vinylpyrrolidinylthio
lower alkyl
carbapenem derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2022681A
Other languages
English (en)
Other versions
CA2022681C (fr
Inventor
Susumu Nakagawa
Fumio Nakano
Norikazu Otake
Ryosuke Ushijima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2022681A1 publication Critical patent/CA2022681A1/fr
Application granted granted Critical
Publication of CA2022681C publication Critical patent/CA2022681C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002022681A 1989-08-04 1990-08-03 Derives de 2-(2-vinylpyrrolidinylthio)carbapenem Expired - Fee Related CA2022681C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP202568/1989 1989-08-04
JP20256889 1989-08-04

Publications (2)

Publication Number Publication Date
CA2022681A1 true CA2022681A1 (fr) 1991-02-05
CA2022681C CA2022681C (fr) 1996-06-18

Family

ID=16459655

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022681A Expired - Fee Related CA2022681C (fr) 1989-08-04 1990-08-03 Derives de 2-(2-vinylpyrrolidinylthio)carbapenem

Country Status (8)

Country Link
US (1) US5095013A (fr)
EP (1) EP0411664B1 (fr)
JP (1) JP2707811B2 (fr)
KR (1) KR910004622A (fr)
AT (1) ATE117302T1 (fr)
AU (1) AU631671B2 (fr)
CA (1) CA2022681C (fr)
DE (1) DE69016121D1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3048196B2 (ja) * 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
WO1993001192A1 (fr) * 1991-07-09 1993-01-21 Banyu Pharmaceutical Co., Ltd. Derives de 2-carbapenem(pyrrolidinylthio substitue en position 2)
KR950014111A (ko) * 1993-11-23 1995-06-15 유충식 새로운 카바페넴 유도체 및 그 제조방법
KR100551853B1 (ko) * 2000-07-19 2006-02-13 에프. 호프만-라 로슈 아게 피리미딘 유도체
WO2011080736A1 (fr) 2009-12-29 2011-07-07 Mapi Pharma Hk Limited Composés intermédiaires et procédés pour la préparation de tapentadol et de composés apparentés

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1281720C (fr) * 1984-11-08 1991-03-19 Makoto Sunagawa Composes de carbapenem et leur production
EP0243686B1 (fr) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Dérivés de bêta-lactame et leur préparation
EP0272455B1 (fr) * 1986-11-24 1993-02-10 Fujisawa Pharmaceutical Co., Ltd. Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-ène-2-carboxylique
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
CA2036941A1 (fr) * 1990-02-23 1991-08-24 Isao Kawamoto Derives du carbapenem ayant une action antibiotique, mode de preparation et d'utilisation
TW198034B (fr) * 1990-03-27 1993-01-11 Manyu Seiyaku Kk

Also Published As

Publication number Publication date
JP2707811B2 (ja) 1998-02-04
DE69016121D1 (de) 1995-03-02
US5095013A (en) 1992-03-10
EP0411664B1 (fr) 1995-01-18
KR910004622A (ko) 1991-03-29
CA2022681C (fr) 1996-06-18
EP0411664A2 (fr) 1991-02-06
AU631671B2 (en) 1992-12-03
AU6012290A (en) 1991-02-07
JPH04154782A (ja) 1992-05-27
ATE117302T1 (de) 1995-02-15
EP0411664A3 (en) 1991-07-24

Similar Documents

Publication Publication Date Title
AU5185386A (en) 1,2 dialkoxy-omega-trialkylammonium cationic surfactants
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
CA2100503A1 (fr) Derives piperidine du benzimidazole
AU2722095A (en) Novel pyrrolocarbazoles
AU8156394A (en) Methods for inhibiting LDL oxidation and atheroclerosis
AU631671B2 (en) 2-(2-vinylpyrrolidinylthio)carbapenem derivatives
AU623500B2 (en) Carboxylimino benzothiazole derivatives
AU7372591A (en) 2-(substituted pyrrolidinylthio)carbapenem derivatives
AP9600800A0 (en) 2-(Pyrazol-3-yl) carbapenem derivatives.
AU7589494A (en) Pyrrolidine derivatives
GR3021045T3 (en) 1-Alkyl-2-acyl-1,2-disulfonylhydrazines with antineoplastic activity
AU630839B2 (en) Sulfinyl imidazole derivatives and antiulcer agents containing the same
GR3015002T3 (en) 1,4-Dihydro-4-oxo-3-quinolone derivatives as selectively toxic mammalian antibacterial agents.
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
AU2001225466A1 (en) Pyrimidine derivatives having antitumor effect

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed